Commentary · 21 Feb 2026
Conference abstractPublished 5 Oct 2015
Surgical ovarian ablation for premenopausal, ER positive women with breast carcinoma in rural India
Government Medical College Palakkad, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In premenopausal women with breast cancer, adjuvant chemotherapy has alone reduced the annual odds of recurrence by 37% and mortality by 27%. Ovarian ablation by surgical means has on its own shown a similar picture with 30% reduction in risk of recurrence and 38% reduction in the incidence of mortality .The clinical benefit of such reduction is now understood to be based on the role of estrogen receptor (ER). The benefit of chemotherapy seems act through the effect of chemical ovarian ablation (either totally or partially). Thus, surgical ovarian ablation may be considered as an adjuvant therapy in premenopausal women who refuse chemotherapy, who are ER positive and who have completed their families and who cannot be relied upon to come for regular clinical follow up. Surgical ovarian ablation can be done laparoscopically along with modified radical mastectomy and obtain the same results as chemotherapy minus its toxic side effects.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Terence B Culas”
